Quinn

The AI that delivers pharma R&D decisions in days, not months

Y CombinatorSummer 2022ActiveHealthcareDrug Discovery and DeliveryArtificial IntelligenceGenerative AIBiotechEnterprise

What they do

Problem

Pharmaceutical R&D teams take months to make high-stakes drug development decisions about what to pursue and how to advance candidates to patients.

Solution

Quinn is an AI system that rapidly generates and supports pharma R&D decisions on drug selection, development priorities, and pathways to patients in days instead of months.

Who it's for

Pharmaceutical and biotech R&D teams making drug development strategy and portfolio decisions.

Founders

Daniel Gomari

Founder/CEO

Daniel Gomari is the founder and CEO of Quinn. A Stanford postdoc and PhD in Computational Biology, his work spanned ML for drug repurposing across cancer and metabolic disease, and multi-omics studies on aging and lifespan extension. He built Quinn after watching the pharma industry make billion-dollar R&D decisions on intuition and slide decks instead of computational evidence.

LinkedIn · X